It has been shown that the PI3K/AKT signaling pathway is dysregulated in almost all human cancers, such as breast cancer [26], gastrointestinal cancer [27], colorectal cancer [28] and ovarian cancer [29], which highlights the potential therapeutic value of this pathway in cancer therapy [30]. The gene discussed is AKT1; the disease is cancer.